Structure Therapeutics Inc (GPCR)

Structure Therapeutics Inc. has seen limited insider activity recently, with a single proposed sale of 35,512 shares valued at approximately $1.71 million by an officer on June 25, 2026. This follows a period where the stock price experienced a 29.2% increase over the last 90 days, with the company's last earnings report released on August 5, 2026.
Ticker: GPCR Exchange: NMS


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
XICHEN LIN Officer Officer
Transaction date
Proposed sale
Price
381.28
Quantity 35,808
Value US$4,904,179
3.0
RAYMOND C STEVENS Officer Officer
Transaction date
Proposed sale
Price
244.71
Quantity 95,665
Value US$3,966,784
XICHEN LIN Officer Officer
Transaction date
Proposed sale
Price
79.60
Quantity 62,604
Value US$2,233,989
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-06-25 2026-06-25 PrS Proposed sale

Officer

Officer
35,808
381.28
US$4,904,179
35,808 381.28 US$4,904,179
2024-06-10 2024-06-10 PrS Proposed sale

Officer

Officer
95,665
244.71
US$3,966,784
95,665 244.71 US$3,966,784
2024-06-03 2024-06-03 PrS Proposed sale

Officer

Officer
62,604
79.60
US$2,233,989
62,604 79.60 US$2,233,989